Going to 11: New Subsections at CDER’s Office of Pharmaceutical Quality Are Important Piece of FDA’s Inspection and Enforcement Strategy By John W.M. Claud —

https://www.thefdalawblog.com/2023/11/going-to-11-new-subsections-at-cders-office-of-pharmaceutical-quality-are-important-piece-of-fdas-inspection-and-enforcement-strategy/?utm_source=rss&utm_medium=rss&utm_campaign=going-to-11-new-subsections-at-cders-office-of-pharmaceutical-quality-are-important-piece-of-fdas-inspection-and-enforcement-strategy